Sara Tolaney, MD, MPH

Sara Tolaney, MD, MPH, is from the Dana-Farber Cancer Institute.

Articles by Sara Tolaney, MD, MPH

Sara Tolaney, MD, MPHTriple-Negative Breast Cancer | June 6, 2025
Sacituzumab + pembrolizumab improved PFS vs chemo in PD-L1+ TNBC in ASCENT-04, with no new safety signals.